Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1999
06/23/1999CN1220163A Drug for curing premenstrual tension
06/23/1999CN1220159A Medicinal liquor for curing proliferation of mammary gland
06/23/1999CN1220157A Kidney-tonifying life-prolonging capsule and its producing method
06/23/1999CN1043764C Bicycle carboxamides as 5-HT1A antagonists
06/23/1999CN1043763C Tropane-aldoxine derivatives and preparation process and use thereof
06/23/1999CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition
06/23/1999CN1043761C Fluorinated hydroxyalkylquinoline acid and medicinal salt and its drug composition
06/23/1999CN1043737C Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample
06/22/1999US5914406 Azepanes and their ring homologues having protein kinase inhibiting activity
06/22/1999US5914346 Using conjugated linoleic acid
06/22/1999US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins
06/22/1999US5914341 Anticarcinogenic agents and enzyme inhibitors
06/22/1999US5914338 Heterocyclic compounds and their preparation and use
06/22/1999US5914332 Retroviral protease inhibiting compounds
06/22/1999US5914329 Dimesylate salts of neuropeptide Y ligands
06/22/1999US5914323 Treating hypercalcemia of malignancy, metastatic bone disease and/or metabolic bone disease by administering an isotonic aqueous alendronate solution with a buffer to maintain the ph in the range 4 to 8 to prevent precipitation
06/22/1999US5914234 Methods of detecting growth differentiation factor-11
06/22/1999US5914126 Methods to deliver macromolecules to hair follicles
06/22/1999US5914106 Interleukin-6 receptor agonists
06/22/1999CA2169066C Phenoxyphenyl cyclopentenyl hydroxyureas
06/22/1999CA2151674C Methods of administering crf antagonists
06/22/1999CA1340608C Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
06/19/1999WO1999032139A1 Improved interferon polymer conjugates
06/19/1999CA2256303A1 The use of mmp inhibitors for the treatment of ocular angiogenesis
06/17/1999WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029861A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029848A1 Novel vectors and genes exhibiting increased expression
06/17/1999WO1999029842A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999WO1999029734A1 Dextran derivatives, preparation method and applications as medicine with specific biological action
06/17/1999WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
06/17/1999WO1999029697A1 Pharmaceuticals
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029687A1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
06/17/1999WO1999029686A1 Novel compounds
06/17/1999WO1999029685A1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2-[(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt
06/17/1999WO1999029674A1 Retinoic acid mimetic anilides
06/17/1999WO1999029673A1 SELECTIVE β3 ADRENERGIC AGONISTS
06/17/1999WO1999029672A1 SELECTIVE β3 ADRENERGIC AGONISTS
06/17/1999WO1999029669A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
06/17/1999WO1999029667A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
06/17/1999WO1999029664A1 New compounds
06/17/1999WO1999029346A1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029323A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999WO1999029321A1 Inhibition of membrane-associated viral replication
06/17/1999WO1999029320A1 Novel administration form comprising an acid-labile active compound
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029308A2 Method for combating obesity
06/17/1999WO1999029299A1 Novel suppository form comprising an acid-labile active compound
06/17/1999WO1999029182A1 Method for purifying heat shock peptides complexes
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016887A3 Compositions and methods for identifying pkb kinase inhibitors
06/17/1999WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use
06/17/1999WO1999015198A3 Agents for combating bacterial meningitis
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1998055075A3 Compositions and methods for inhibiting photoaging of skin
06/17/1999DE19803206C1 New tetrakis-carboranylmethyl-propane derivatives useful in boron neutron capture tumor therapy or as labeling agents in energy filtering transmission electron microscopy
06/17/1999DE19755268A1 Benzamidinderivate Benzamidine derivatives
06/17/1999DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313390A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312987A1 Selective .beta.3 adrenergic agonists
06/17/1999CA2312965A1 (e)-3-¬1-n-butyl-5-¬2-(2-carboxyphenyl)methoxy-4-chlorophenyl|-1h-pyrazol-4-yl|-2-¬(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl|-prop-2-enoic acid monoargininyl salt
06/17/1999CA2312849A1 Selective .beta.3 adrenergic agonists
06/17/1999CA2312844A1 Pharmaceuticals
06/17/1999CA2312760A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999CA2312720A1 Retinoic acid mimetic anilides
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312423A1 Inhibition of membrane-associated viral replication
06/17/1999CA2312357A1 Novel compounds
06/17/1999CA2312291A1 Novel vectors and genes exhibiting increased expression
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2312049A1 Method for purifying heat shock peptides complexes
06/17/1999CA2312006A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them
06/16/1999EP0922762A1 Drug binding protein
06/16/1999EP0922760A2 Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF)
06/16/1999EP0922703A1 Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds
06/16/1999EP0922454A2 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
06/16/1999EP0922045A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
06/16/1999EP0922042A1 Novel piperazine containing compounds
06/16/1999EP0922036A1 Arylalkanoyl pyridazines
06/16/1999EP0922034A1 Tetrahydroquinoline derivatives as eaa antagonists
06/16/1999EP0922028A1 Inhibitors of phospholipase enzymes
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921809A1 Use of prolactin as a tgf-beta antagonist
06/16/1999EP0921806A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
1 ... 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 ... 1564